Brief: Geneuro announces first patient treated in phase 2A study with GNBAC1 in type 1 diabetes

Geneuro SA

19/06/2017 06:35

June 19 (Reuters) - GENEURO SA  GNRO.PA : 
    * ANNOUNCES FIRST PATIENT TREATED IN PHASE 2A STUDY WITH GNBAC1 IN TYPE 1 DIABETES 
    * AUSTRALIAN PHASE 2A CLINICAL STUDY PLANS TO ENROLL 60 ADULT PATIENTS IN OVER 10 CENTERS 
    * LAST PATIENT ENROLMENT IS EXPECTED BY END 2017 
 
Source text for Eikon:  ID:nBw99MQWQa  
Further company coverage:  GNRO.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))